EQUINE SUPPLIES

Brand Owner (click to sort) Address Description
ARCTICQUILT JT INTERNATIONAL DISTRIBUTORS, INC. 12607 Southeastern Ave. Indianapolis IN 46259 equine supplies, namely, horse blankets, equine hoods;ARCTIC QUILT;
GAUCHOLIFE Luchetta, Marcos Alejandro Arroyo 897, 13E Caba 1007 Argentina equine supplies, namely, horse bits, bridles, curb straps, nosebands, breast collars, tie down straps, cavesons, and reins;
IGEL IG Holdings 15833 West Judd Street Ettrick WI 54627 Equine supplies, namely, pads for horse saddles, horse shoe pads, horse and pony blankets and sheets bridles and reins, horse halters and leads, horse girths, saddles, nosebands, cavesons, whips, equine leg wraps, boots and shin guards, travel bags for equestrian equipment and horse bits;I GEL;
SAFARI LINE Impact Gel Holdings 204 N WASHINGTON ST MELRSOE WI 54642 Equine supplies, namely, saddle pads;LINE;
STERLING HELLER IG Holdings 15833 West Judd Street Ettrick WI 54627 Equine supplies, namely, pads for horse saddles, horse shoe pads, horse and pony blankets and exercise sheets; Horse tack, namely, bridles and reins, horse halters and leads and horse girth straps and saddles; horse headstalls, namely, nosebands and cavesons; equine supplies, namely, whips, equine leg wraps, protective padding and leg boots for horse shanks; travel bags for equestrian equipment and horse bits;The name(s), portrait(s), and/or signature(s) shown in the mark does not identify a particular living individual.;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. This invention relates to the development of a mammalian expression vector, under which expression of the structural genes of western equine encephalitis virus have been placed under the control of an eucaryotic promoter. When the recombinant vector is administered to mammalian cell culture or using a cell-free transcription/translation system, in vitro, authentic structural proteins of western equine encephalitis virus are produced as verified by reactivity with monoclonal antibodies developed to western equine encephalitis virus. When the recombinant DNA molecule is administered in vivo, a protective immune response is induced, thereby enhancing protection of the individual against subsequent infection by western equine encephalitis virus. In a similar manner, DNA vaccines to related alphaviruses (Venezuelan and eastern equine encephalitis viruses) could also be developed.